Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medco “Fallback” Comments Create Fallout On Capitol Hill

Executive Summary

Medco and other pharmacy benefit managers that have said they will not offer a Part D prescription drug plan should wait to see the implementing regulations before making a decision, Centers for Medicare & Medicaid Services Senior Policy Advisor Tim Trysla said

You may also be interested in...



PBMs Still Skeptical Of Part D; Is “Donut Hole” A Lifesaver?

Potential Medicare prescription drug insurance plan providers should consider the "donut hole" to be a form of reinsurance that limits their exposure to risk, the Centers for Medicare & Medicaid Services suggests

PBMs Still Skeptical Of Part D; Is “Donut Hole” A Lifesaver?

Potential Medicare prescription drug insurance plan providers should consider the "donut hole" to be a form of reinsurance that limits their exposure to risk, the Centers for Medicare & Medicaid Services suggests

Medco Committed To Medicare Rx, But Not Part D; Backing The “Fallback”

Medco is prepared to invest $150 mil. to create dedicated, Medicare-only facilities for the drug benefit in 2006, CFO JoAnn Reed told the Goldman Sachs conference in Laguna Niguel, Calif. June 9

Related Content

UsernamePublicRestriction

Register

PS044205

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel